PMID- 26888804 OWN - NLM STAT- MEDLINE DCOM- 20160915 LR - 20181202 IS - 0253-3758 (Print) IS - 0253-3758 (Linking) VI - 43 IP - 11 DP - 2015 Nov TI - [Relationship between hyperhomocysteine and long-term outcome of coronary artery disease patients after drug-eluting stent implantation]. PG - 943-7 AB - OBJECTIVE: To explore the relationship between hyperhomocysteinemia (H-Hcy) and long-term outcome of coronary artery disease (CAD) patients after drug-eluting stent (DES) implantation in a single centre. METHODS: A total of 1 408 consecutive patients implanted with DES in our department between March 2011 and January 2013 were enrolled in this prospective study. Patients were stratified into H-Hcy (Hcy>/=10 micromol/L, n=798, 56.7%) and non-H-Hcy group (Hcy<10 micromol/L, n=610, 43.3%). The clinical characteristics, coronary artery lesions, SYNTAX score and 1-year major adverse cardiac and cerebrovascular events (MACCE) were compared between the two groups. RESULTS: Compared with non-H-Hcy group, coronary artery stenosis was severer as shown by higher diseased arteries (2.11+/-0.87 vs. 1.91+/-0.82, P<0.001), higher incidence of three diseased arteries (39.7% vs. 29.5%, P<0.001) and higher SYNTAX score (36.99+/-29.66 vs. 27.39+/-22.70, P=0.001) in H-Hcy group. The 1-year incidence of MACCE was also higher in H-Hcy group compared with non-H-Hcy group(18.4% vs. 8.9%, P<0.001). Multivariate Cox analysis showed that diabetes mellitus (OR=1.530, 95%CI 1.142-2.050, P=0.004), age (OR=1.065, 95%CI 1.038-1.093; P<0.001), and Hcy (OR=1.019, 95%CI 1.005-1.033, P=0.009) are the independent predictors for 1-year MACCE. CONCLUSION: High Hcy level is correlated with the severity of coronary artery stenosis, and serves as an independent predictor of MACCE after stenting in CAD patients. FAU - Yan, Gaoliang AU - Yan G AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Wang, Dong AU - Wang D AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Qiao, Yong AU - Qiao Y AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Kong, Wenjie AU - Kong W AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Sha, Xiang AU - Sha X AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Cheng, Tianyu AU - Cheng T AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Zhang, Hairong AU - Zhang H AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Hou, Jiantong AU - Hou J AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. FAU - Tang, Chengchun AU - Tang C AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China; Email: tangchengchun@medmail.com.cn. FAU - Ma, Genshan AU - Ma G AD - Department of Cardiology, Zhongda Hospital of Southeast University Medical School, Nanjing 210009, China. LA - chi PT - Journal Article PL - China TA - Zhonghua Xin Xue Guan Bing Za Zhi JT - Zhonghua xin xue guan bing za zhi JID - 7910682 RN - 0LVT1QZ0BA (Homocysteine) SB - IM MH - *Coronary Artery Disease MH - *Drug-Eluting Stents MH - Homocysteine MH - Humans MH - Prospective Studies MH - Time Factors MH - Treatment Outcome EDAT- 2016/02/19 06:00 MHDA- 2016/09/16 06:00 CRDT- 2016/02/19 06:00 PHST- 2016/02/19 06:00 [entrez] PHST- 2016/02/19 06:00 [pubmed] PHST- 2016/09/16 06:00 [medline] PST - ppublish SO - Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Nov;43(11):943-7.